An epigenetic test tells you how old your body actually is.
Not how old you are — how old your cells are. The number can be years above or below what your passport says.
Think of two cars with 100,000 miles on the odometer. One falls apart at the next pothole. The other still runs like new. Your DNA is the odometer. Your epigenetic age is the engine.
That's the whole pitch. The reason 40% of high-performing adults over 35 who run one walk away with a number that surprises them. Mine surprised me.
Here's what an epigenetic test actually is, how the science works, the three clocks worth knowing, what a kit costs, and — most importantly — what the test can't do. So you can decide whether $350 is worth it.
Your DNA doesn't change much over your lifetime. It's the same sequence of letters you were born with. What changes is the chemistry sitting on top of it.
Small chemical marks — called methylation tags — attach to specific spots on your DNA. They turn genes louder or quieter, like dimmer switches in a house. They shift constantly. With age. With stress. With sleep. With sunlight. With basically everything you do.
The breakthrough: those shifts happen in predictable patterns as you age.
So if you read enough of them at once — hundreds of thousands of spots — you can estimate how old someone's body is biologically. From a single blood sample.¹
The math behind that estimate is called an epigenetic clock.
There are several of them. Each one is trained slightly differently — on different data, for different purposes. The first widely-validated clock came out of Steve Horvath's lab at UCLA in 2013 and works across any tissue type.² Since then, four more clocks have been built, each better than the last at predicting what actually matters: not just age, but the rate you're aging, and your risk of developing disease.
There's a handful of these out there. Most people only need to know three:
The Horvath clock — the original (2013). Reads your DNA, gives you a biological age. Works across nearly any tissue type. The most replicated clock in the research, but it tends to underestimate the impact of recent lifestyle changes — it was trained on chronological age, not on health outcomes.²
GrimAge — the heavy one. Predicts how likely you are to develop chronic disease, cognitive decline, or die early.³ Trained on time-to-death data plus DNA-methylation surrogates for smoking and plasma proteins. If your GrimAge is meaningfully accelerated, mortality risk is genuinely elevated across multiple large cohorts. Worth tracking annually if you're a high performer who's been running hot.
DunedinPACE — the new one, and the one I track. Doesn't give you an age at all. Gives you a speed. Built from 20 years of longitudinal data on 1,037 New Zealanders born in 1972, tracking which methylation patterns captured how fast their physiology was actually declining.⁴ A score of:
- 1.0 = aging at the average pace
- 1.15 = aging 15% faster than average
- 0.85 = aging 15% slower
DunedinPACE matters more than the other two — and it's worth understanding why.
Biological age tells you where you are. Rate of aging tells you which direction you're moving.
You can't change your starting point. You can change your trajectory.
That's why anyone running a longevity protocol cares more about DunedinPACE than the snapshot. Move your DunedinPACE from 1.05 down to 0.95 and you've measurably changed the rate your cells are wearing out. The Horvath number will follow, but slowly. DunedinPACE is the leading indicator.
DunedinPACE is also the clock that responds fastest to lifestyle change — research shows it can move within weeks of intervention.⁴ The other clocks take months. So if you're running a protocol and want feedback on whether it's working, DunedinPACE is the metric.
Worth being honest about: the clocks aren't perfect.
On the biological-age number, expect about ±3-5 years of error. If your test says biological age 38 and you're chronologically 35, the real signal isn't "you're exactly 3 years older." It's "your cells look more like a 38-year-old's than a 35-year-old's." Useful — but not precise.
On DunedinPACE, accuracy is tighter. A 2022 Nature Aging paper introduced principal-component-based versions of the clocks that significantly improved reliability — meaning the same blood sample run twice gives closer answers.⁵ Most reputable commercial labs now use these reliability-corrected versions.
Test-retest variability is the practical issue. If you ran the same sample today and again next week, you wouldn't get the exact same number. Most clocks vary 1-2 years sample-to-sample. DunedinPACE varies a fraction of a unit.
That's why a single test gives you a snapshot, but the real signal shows up across 2-4 tests over a year. Direction matters more than absolute number.
A lot of marketing makes epigenetic testing sound like a crystal ball. It isn't.
- It doesn't diagnose disease. If your biological age is elevated, something is driving accelerated aging — but the test doesn't tell you what. Standard bloodwork and a physician are still required.
- It's not a cancer screen. GrimAge predicts all-cause mortality risk in aggregate. It doesn't predict any specific disease.
- It doesn't replace your annual physical. Mammograms, colonoscopies, blood pressure tracking — none of this is obsolete because you ran an epigenetic test.
- It doesn't measure how you feel. Some people with elevated biological age feel fine. Some people with normal biological age feel terrible.
- It doesn't determine your future. Biological age responds to intervention. Your number today doesn't lock in your number a year from now. That's the entire point.
If anyone is selling you an epigenetic test as a "complete health snapshot" or "ultimate predictor" — they're misrepresenting what the technology does.
What it does: it makes invisible things visible. If you're going to do something with the result, it's worth $350. If you'll read the number, feel anxious, and do nothing — save your money.
A few reputable consumer providers exist. The one I use, and the one KINS uses for every guest, is TruDiagnostic (trudiagnostic.com). No affiliate relationship — this link goes directly to their site. We use them because:
- Their TruAge panel runs multiple clocks (Horvath, PhenoAge, GrimAge, DunedinPACE, Symphony Age) from one sample
- The lab is CLIA-certified
- They use the reliability-corrected (principal-component) clock versions
- The lab runs on Illumina's 850K EPIC array — the industry standard
The process:
- Order the kit (~$350 — sometimes lower with practitioner codes)
- Provide a sample — finger-prick blood spot or phlebotomy draw. Both are validated; finger-prick is more convenient.
- Mail it in. Results land in your inbox as a 47-page PDF in roughly six weeks.
Other options include Elysium Index, Hooke, and MyDNAge. I'll compare these properly in a separate post, but the short version: TruDiagnostic has the best combination of clock breadth + reliability + price.
When the PDF lands, focus in this order:
Ready to experience data-driven longevity?
Book a Discovery Call →- DunedinPACE first. If it's above 1.0, you're aging faster than average. That's the leading indicator and the metric you'll want to move.
- GrimAge vs. chronological. If GrimAge is meaningfully above your chronological age, this is the most prognostically loaded signal. Talk to a clinician.
- Composite biological age vs. chronological. The headline number on page two. Take it ±3-5 years.
- Organ-system breakdown (Symphony Age, on TruDiagnostic). This is where the test gets actually useful. The composite hides what the breakdown surfaces — like the fact that my composite came back younger than chronological, but my Hormone system came back 8.7 years older than chronological. That's the founder-stress signal you can act on.
What's NOT worth focusing on:
- Individual CpG site readouts (research-only)
- Single-tissue clocks unless you have a specific clinical reason
- Telomere length (still controversial, less validated)
How often should I retest?
Every 6 months. More frequently and you're paying for noise. Less and you can't tell if your protocol is working.
Is it worth $350?
Depends on what you'll do with the data. If you'll run a protocol and retest, yes. If you'll read the number, feel anxious, and do nothing — address the underlying behaviors first.
Does insurance cover it?
Almost never. Insurance covers diagnostic tests for disease. Epigenetic age testing is preventive — which insurers categorize as elective.
What's the difference between an epigenetic test and a genetic test?
A genetic test (like 23andMe) reads your DNA sequence — what you were born with. An epigenetic test reads the chemical marks on top of that DNA — what's changed since. Genetic tests don't change over time. Epigenetic tests do.
Can I run an epigenetic test from saliva instead of blood?
Yes. Saliva-based methylation testing is validated, though blood gives slightly higher signal quality. TruDiagnostic offers both.
Where do I order one?
TruDiagnostic is what I use and what KINS uses. No affiliate relationship — that's just the brand I'd pick if starting from scratch.
An epigenetic age test isn't a crystal ball, a disease screen, or a wellness gimmick. It's a measurement tool that surfaces what's already happening to your cells. For high-performing adults who've been running on a deficit for years — long sleep debt, chronic stress, accumulated inflammation — it's often the first diagnostic that makes the invisible visible.
At KINS, every guest begins with a TruAge panel on arrival. The 14-day protocol is built around what that panel reveals. The departure test shows what's already moving.
This is the explainer I wish existed when I was deciding whether the technology was real.
It is. Use it accordingly.
— Cathy
Up next: What an epigenetic test actually told me — what showed up when I ran one (the organ-system breakdown was the surprise, not the headline number). And a soon-to-publish comparison piece: TruDiagnostic vs Elysium vs MyDNAge vs Hooke.
- Horvath S (2013). DNA methylation age of human tissues and cell types. Genome Biology, 14(10), R115. PubMed
- Hannum G, et al. (2013). Genome-wide methylation profiles reveal quantitative views of human aging rates. Molecular Cell, 49(2), 359-367. PubMed
- Lu AT, et al. (2019). DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging, 11(2), 303-327. PubMed
- Belsky DW, et al. (2022). DunedinPACE, a DNA methylation biomarker of the pace of aging. eLife, 11, e73420. PubMed
- Higgins-Chen AT, et al. (2022). A computational solution for bolstering reliability of epigenetic clocks. Nature Aging, 2, 644-661. Nature
- Levine ME, et al. (2018). An epigenetic biomarker of aging for lifespan and healthspan. Aging, 10(4), 573-591. PubMed
- Belsky DW, et al. (2020). Quantification of the pace of biological aging in humans through a blood test, the DunedinPoAm DNA methylation algorithm. eLife, 9, e54870. PubMed
- Faul JD, et al. (2023). Epigenetic-based age acceleration in a representative sample of older Americans: Associations with aging-related morbidity and mortality. PNAS, 120(9). PubMed